WallStreetZenWallStreetZen

NASDAQ: ACHL
Achilles Therapeutics PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ACHL

Based on 3 analysts offering 12 month price targets for Achilles Therapeutics PLC.
Min Forecast
$0.50-37.5%
Avg Forecast
$2.83+254.13%
Max Forecast
$6.00+650%

Should I buy or sell ACHL stock?

Based on 3 analysts offering ratings for Achilles Therapeutics PLC.
Hold
Strong Buy
1 analysts 33.33%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
1 analysts 33.33%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACHL stock forecasts and price targets.

ACHL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-05
lockedlocked$00.00+00.00%2024-04-05
lockedlocked$00.00+00.00%2023-12-14

1 of 1

Forecast return on equity

Is ACHL forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is ACHL forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ACHL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACHL$0.80$2.83+254.13%Hold
IPA$1.24$7.00+464.52%Buy
VYNE$2.30$5.75+150.00%Buy
EVGN$0.64N/AN/A
ACXP$2.13$12.00+463.38%Buy
View Top Biotech Stocks

Achilles Therapeutics Stock Forecast FAQ

Is Achilles Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ACHL) stock is to Hold ACHL stock.

Out of 3 analysts, 1 (33.33%) are recommending ACHL as a Strong Buy, 0 (0%) are recommending ACHL as a Buy, 1 (33.33%) are recommending ACHL as a Hold, 1 (33.33%) are recommending ACHL as a Sell, and 0 (0%) are recommending ACHL as a Strong Sell.

If you're new to stock investing, here's how to buy Achilles Therapeutics stock.

What is ACHL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ACHL) forecast ROE is N/A, which is considered weak.

What is ACHL's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ACHL price target, the average ACHL price target is $2.83, with the highest ACHL stock price forecast at $6.00 and the lowest ACHL stock price forecast at $0.50.

On average, Wall Street analysts predict that Achilles Therapeutics's share price could reach $2.83 by Apr 5, 2025. The average Achilles Therapeutics stock price prediction forecasts a potential upside of 254.13% from the current ACHL share price of $0.80.

What is ACHL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ACHL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.